BioPharma Credit Posts Lower H1 Return, Total Income

MT Newswires · 1d ago
02:31 AM EDT, 09/24/2026 (MT Newswires) -- BioPharma Credit (BPCP.L, BPCR.L) said Thursday that its return and total income declined year over year in the first half. Return for the six months ended June 30 was $50.4 million, compared with $72.8 million earlier. Net revenue and capital return per ordinary share moved to $0.0447 from $0.0633. The investment company's total income was $57.4 million, compared with $83.8 million a year ago.